1. www.ema.europea.eu European Medicines Agency

2. Zapun A., Contreras-Martel C., Vernet T. Penicillin- binding proteins and β-lactam resistance. FEMS Microbiol. Rev. 2008. 32: 361-385.

3. Garan J. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae. 2004. Clin. Microbiol. Infect. 10 Suppl. 2: 28-35.

4. European Committee on Antimicrobial Susceptibility Testing. Breakpoints tables for interpretation of MICs and zone diameters. Version 3.1, 2013. http://www.eucast.org

5. Ahmetagić S., Jusufocić E., Ceugić D. i wsp. Analysis of amoxicillin- clavulanic acid (Xiclav) efficacy and the possibility of Elary swich from parental to oral therapy in the treatment of infections. 2003. Med. Arh. 57(5-6):263-266.

6. Salerno F., Cazzaniga M. Terapeutic strategies and emergence of multiresistant bacterial strains. 2010. Intern. Emerg. Med. 5 Suppl. 1: 45-51.

7. Roede B. M., Bresser P., El Monssaoui R. i wsp. Three vs 10

days of amoxicillin-clavulanic acid for type 1 acute exacerbation of chronic obstructive pulmonary disease: a randomized, doubleblind study. 2007. Clin. Microbiol. Infect. 13(3): 284-290.

8. Brook I., Foote P. A., Hausfeld J. N. Eradication of pathogens from the nosopharynx after therapy of acute maxillary sinusitis with low or high-dose amoxicillin/clavulanic acid. 2005. Int. J. Antimicrob. Agents. 26(5): 416-419.

9. Brambilla C., Kastanakis S., Knight S. i wsp. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of Lower respiratory tract infections. 1992. Eur. J. Clin. Microbiol. Infect. Dis. 11(2): 118-124.

10. Sempios I. I., Dimopoulos G., Korbilla I. P. i wsp. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta- analysis. 2007. Eur. Resp. J. 29:1127-1137.

11. Ricart E., Soriano G., Novella M. T. i wsp. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infection in cirrhotic patients. 2000. J. Hepatol. 32(4): 596-602.

12. Sulejmanagić N., Sulejmanagić H., Ljutović Z. i wsp. Combined application of amoxicillin and clavulanic acid after oral surgical interventions. 2005. Bosn. J. Basic. Med. Sci. 5(1): 61-68.

13. Gresser U., Amoxicillin-clavulanic acid therapy may be associated with severe side effects – review of the literature. 2001. Eur. J. Med. Rev. 6(4): 139-149.

14. Benyamini L., Merlob P., Stahl B. i wps. The safety of amoxicillin/ clavulanic acid and cefuroxime duringlactation. 2005. Ther. Drug Monit. 27(4): 499-502.

15. Salvo F., De Sarro A., Caputi A. P. i wsp. Amoxicillin and amoxicillin plus clavulanate: a safety review. 2009. Expert. Opin. Drug. Saf. 8(1): 111-118. dr n